Alveolar Rhabdomyosarcoma–associated PAX3-FOXO1 Promotes Tumorigenesis via Hippo Pathway Suppression

Journal of Clinical Investigation - United States
doi 10.1172/jci67087
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Alveolar Rhabdomyosarcoma – The Molecular Drivers of PAX3/7-FOXO1-induced Tumorigenesis

Skeletal Muscle
OrthopedicsSports MedicineCell BiologyMolecular Biology
2012English

Inhibiting Phosphorylation of the Oncogenic PAX3-FOXO1 Reduces Alveolar Rhabdomyosarcoma Phenotypes Identifying Novel Therapy Options

Oncogenesis
Cancer ResearchMolecular Biology
2015English

Sphingosine Induces Apoptosis and Down-Regulation of MYCN in PAX3–FOXO1-positive Alveolar Rhabdomyosarcoma Cells Irrespective of TP53 Mutation

Anticancer Research
MedicineCancer ResearchOncology
2018English

WWC Proteins Regulate Hepatic Cell Differentiation and Tumorigenesis via the Hippo Signaling Pathway

Hepatology
MedicineHepatology
2018English

PAX3/7–FOXO1 Fusion Status in Older Rhabdomyosarcoma Patient Population by Fluorescent in Situ Hybridization

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2011English

P-Cadherin Is a Direct PAX3–FOXO1A Target Involved in Alveolar Rhabdomyosarcoma Aggressiveness

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Carnitine Palmitoyltransferase 1A (CPT1A): A Transcriptional Target of PAX3-FKHR and Mediates PAX3-FKHR–dependent Motility in Alveolar Rhabdomyosarcoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

PAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in Alveolar Rhabdomyosarcoma Cells

Journal of Cancer Research Updates
2012English

MiR-590-3p Promotes Proliferation and Metastasis of Colorectal Cancer via Hippo Pathway

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy